ART-CHEM-BB B014631
- $126 - $541
- Product name: ART-CHEM-BB B014631
- CAS: 870540-23-1
- MF: C11H16N2O3S
- MW: 256.32
- EINECS:
- MDL Number:MFCD03422689
- Synonyms:ART-CHEM-BB B014631;Butyl 2-amino-5-(aminocarbonyl)-4-methylthiophene-3-carboxylate;3-Thiophenecarboxylic acid, 2-amino-5-(aminocarbonyl)-4-methyl-, butyl ester
4 prices
Selected condition:
Brand
- Arctom
- Crysdot
- Matrix Scientific
Package
- 500mg
- 1g
- 5g
- ManufacturerArctom
- Product numberAS051892
- Product descriptionButyl2-amino-5-carbamoyl-4-methylthiophene-3-carboxylate 97%
- Packaging1g
- Price$180
- Updated2021-12-16
- Buy
- ManufacturerArctom
- Product numberAS051892
- Product descriptionButyl2-amino-5-carbamoyl-4-methylthiophene-3-carboxylate 97%
- Packaging5g
- Price$541
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11040012
- Product descriptionButyl2-amino-5-carbamoyl-4-methylthiophene-3-carboxylate 97%
- Packaging5g
- Price$541
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number029212
- Product descriptionButyl 2-amino-5-(aminocarbonyl)-4-methylthiophene-3-carboxylate
- Packaging500mg
- Price$126
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Arctom | AS051892 | Butyl2-amino-5-carbamoyl-4-methylthiophene-3-carboxylate 97% | 1g | $180 | 2021-12-16 | Buy |
Arctom | AS051892 | Butyl2-amino-5-carbamoyl-4-methylthiophene-3-carboxylate 97% | 5g | $541 | 2021-12-16 | Buy |
Crysdot | CD11040012 | Butyl2-amino-5-carbamoyl-4-methylthiophene-3-carboxylate 97% | 5g | $541 | 2021-12-16 | Buy |
Matrix Scientific | 029212 | Butyl 2-amino-5-(aminocarbonyl)-4-methylthiophene-3-carboxylate | 500mg | $126 | 2021-12-16 | Buy |
Properties
Boiling point :352.3±42.0 °C(Predicted)
Density :1.259±0.06 g/cm3(Predicted)
pka :16.10±0.50(Predicted)
Density :1.259±0.06 g/cm3(Predicted)
pka :16.10±0.50(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|